268 related articles for article (PubMed ID: 18775121)
21. Optimal renin-angiotensin system blockade-wishful thinking?
Makani H; Bangalore S; Messerli FH
Nat Rev Cardiol; 2013 Aug; 10(8):486. PubMed ID: 23817190
[No Abstract] [Full Text] [Related]
22. Impact of ACE2 gene polymorphism on antihypertensive efficacy of ACE inhibitors.
Chen YY; Liu D; Zhang P; Zhong JC; Zhang CJ; Wu SL; Zhang YQ; Liu GZ; He M; Jin LJ; Yu HM
J Hum Hypertens; 2016 Dec; 30(12):766-771. PubMed ID: 27121444
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway.
Koka V; Huang XR; Chung AC; Wang W; Truong LD; Lan HY
Am J Pathol; 2008 May; 172(5):1174-83. PubMed ID: 18403595
[TBL] [Abstract][Full Text] [Related]
24. Sex-Specific Modulation of Blood Pressure and the Renin-Angiotensin System by ACE (Angiotensin-Converting Enzyme) 2.
Ji H; de Souza AMA; Bajaj B; Zheng W; Wu X; Speth RC; Sandberg K
Hypertension; 2020 Aug; 76(2):478-487. PubMed ID: 32564694
[TBL] [Abstract][Full Text] [Related]
25. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
[TBL] [Abstract][Full Text] [Related]
26. Apelin is a positive regulator of ACE2 in failing hearts.
Sato T; Suzuki T; Watanabe H; Kadowaki A; Fukamizu A; Liu PP; Kimura A; Ito H; Penninger JM; Imai Y; Kuba K
J Clin Invest; 2013 Dec; 123(12):5203-11. PubMed ID: 24177423
[TBL] [Abstract][Full Text] [Related]
27. Dietary peptides from the non-digestible fraction of Phaseolus vulgaris L. decrease angiotensin II-dependent proliferation in HCT116 human colorectal cancer cells through the blockade of the renin-angiotensin system.
Luna-Vital DA; Liang K; González de Mejía E; Loarca-Piña G
Food Funct; 2016 May; 7(5):2409-19. PubMed ID: 27156533
[TBL] [Abstract][Full Text] [Related]
28. [Dual blockade of the renin-angiotensin system in hypertensive treatment: no].
van der Giet M
Dtsch Med Wochenschr; 2012 Nov; 137(48):2499. PubMed ID: 23168984
[No Abstract] [Full Text] [Related]
29. Discovery and characterization of ACE2 - a 20-year journey of surprises from vasopeptidase to COVID-19.
Hooper NM; Lambert DW; Turner AJ
Clin Sci (Lond); 2020 Sep; 134(18):2489-2501. PubMed ID: 32990314
[TBL] [Abstract][Full Text] [Related]
30. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules.
Li N; Zimpelmann J; Cheng K; Wilkins JA; Burns KD
Am J Physiol Renal Physiol; 2005 Feb; 288(2):F353-62. PubMed ID: 15467007
[TBL] [Abstract][Full Text] [Related]
31. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
32. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.
Ponticelli C; Cucchiari D
J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033
[No Abstract] [Full Text] [Related]
33. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of the renin angiotensin system: proven benefits, unproven safety.
Parfrey PS
Ann Intern Med; 2008 Jan; 148(1):76-7. PubMed ID: 17984483
[No Abstract] [Full Text] [Related]
35. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
Tempelhof MW
South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
[No Abstract] [Full Text] [Related]
36. ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Singh N; Joshi S; Guo L; Baker MB; Li Y; Castellano RK; Raizada MK; Jarajapu YP
Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1697-707. PubMed ID: 26386115
[TBL] [Abstract][Full Text] [Related]
37. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
38. Effects of natural peptides from food proteins on angiotensin converting enzyme activity and hypertension.
Martin M; Deussen A
Crit Rev Food Sci Nutr; 2019; 59(8):1264-1283. PubMed ID: 29244531
[TBL] [Abstract][Full Text] [Related]
39. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
Ram CV
Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
[TBL] [Abstract][Full Text] [Related]
40. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
